1Marty A,Meanger J,Mills J,et al.Association of matrix protein of respiratory syncytial virus with the host cell membrane of infected cells.Arch Virol,2004,149:199-210.
2Tripp RA.Pathogenesis of respiratory syncytial virus infection.Viral Immuonl,2004,17:165-181.
3LeVine AM,Elliot J,Whitsett J,et al.Surfactant protein-D enhances phagocytosis and pulmonary clearance of respiratory syncytial virus.Am J Respir Cell Mol Biol,2004,31:193-199.
5Haynes LM,Moore DD,Kurt-Jones EA,et al.Involvement of tolllike receptor 4 in innate immunity to respiratory syncytial virus.J Virol,2001,75:10730-10737.
6Monick MM,Yarovinsky TO,Powers LS,et al.Respiratory syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin.J Biol Chem,2003,278:53035-53044.
7Haeberle HA,Takizawa R,Casola A,et al.Respiratory syncytial virus-induced activation of nuclear factor-kappa B in the lung involves alveolar macrophages and toil-like receptor 4-dependent pathways.J Infect Dis,2002,186:1199-1206.
8Gagro A,Tominac M,Krsulovic-Hresic V,et al.Increased Toll-like receptor 4 expression in infants with respiratory syncytial virus brochiolitis.Clin Exp Immunol,2004,135:267-272.
9Ehl S,Bischoff R,Ostler T,et al.The role of Toll-like receptor 4 versus interleukin-12 in immunity to respiratory syncytial virus.Eur J Immunol,2004,34:1146-1153.
10Vogel AM,Lennon DR,Broadbent R,et al.Palivizumab prophylaxis of respiratory syncytial virus infection in high-risk infants.J Pediatr Child Health,2002,38:550-554.
